Hospital Le Dantec Avenue Pasteur Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2006
NCT00100568
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Laboratoire de Bacteriologic et de Virologie, Hospital Le Dantec Avenue Pasteur

Active Ingredients

Drugs in Other Trials (3)

efavirenz (sustiva) (1 trial)

lamivudine (epivir) (1 trial)

zidovudine (retrovir) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3